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The thymus is essential for the development of cellular immune ecaisms and for the reconstitution ofthe immunological system if damaged, for example, by radiation. The thymus is also implicated in certain types of humoral immunity probably due to co-operation between thymusderived and bursa-derived lymphocytes (see Roitt et al. 1969) . In addition to the link with immunological deficiency, it would therefore be reasonable to ask if some abnormality of the thymus might not be associated with other disorders of the immunological system, such as occur in autoimmunity.
The association between morphological abnormalities of the thymus and conditions characterized by disordered immunological function is impressive (Table 1) . This is not a comprehensive review ofall the various conditions that have ben associated with thymic pathology, but it includes the most important ones. For a detailed account see Irvine (1967) and Goldstein & Mackay (1969) .
CLINICAL CONDMIIONS IN MAN
Myasthenia Gravis Myasthenia gravis is the condition linked with autoimmunity that shows the clearest correlation with thymic pathology. Approximately 10% of patients with myasthenia gravis have thymomas. The classical forms of thymoma that are associated with myasthenia gravis are the predominantly lymphoid and the predominantly epithelioid types. The spindle cell type is not associated with myasthenia gravis. When a thymoma consisting of abundant lymphocytes and plump ovoid epithelioid cells is removed from a patient (Castleman 1966) . According to Lattes (1962) , patients with thymoma invariably show germinal centres in the surrounding thymus tissue. An important clinical point is that the presence of a ma may not be shown by conventional radiogrphy even with tomography.
Pneumo phy may be required to diffniate t outline of the thymoma from other tissues in the anterior mediastinum (Hare & Mackay 1963 , Irine & Sumerling 1965 , Kreel & Jams 1965 , Sumeling & Irvine 1966 ).
In the 90% of patients with yasthenia gravis without a thymoma, the thymus is of normal size, but the i of these patients show a marked degree of grminal centre formation in the medulla of the thymus and an increase in the number ofpasma cel. In fact in only about 15 % of patients is the thymus histologically nc.mal.
The histologial appearance of g i centre formation in the thymus in myasthenia gravis and its resemblance to that of the thyroid in Hashimoto's thyroiditis first prompt the suggestion by Smithers (1959) that myasthenia gravis may be of autoimmune origin.
ThyroidAutoimmune Diseases (Thyrotoxicosis, Hashimoto's Thyroiditis and Primary Atrophic Hypothyroidism) It has long been recognized from post-mortem studies that enlargement of the thymus gland and germinal centre formation in the medulla may occur in thyroid disease, particularly in thyrotoxicosis. More recently, the thymus in thyroid disease has been studied radiologically and by thymus biopsy during the course of routine partial thyroidectomy for thyrotoxicosis or simple goitre (Gunn et al. 1964 , Irvine & Sumerling 1965 . All the patients wereveuthyroid at the time of study. The size of the thymus shadow in the sagittal plane was measured by planimetry.
Those with evidence of autoimmunity in the form of thyroid or gastric antibodies in the serum were found to have considerably larger thymus shadows than in the non-autoimmune cases. The X-ray, of course, does not indicate how much of the thymus shadow is connective tissue (as a result of involution) or how much is thymic cortex or medulla. To overcome this, Michie et al. (1967) calculated the 'corrected thymus size', this being the product of the radiological measurement of thymus size and the percentage of parenchyma in a biopsy of the thymus. Patients who were under treatment for thyrotoxicosis had an increased amount of thymus tissue which often contained germinal centres in the medulla. The occurrence of germinal centres in the thymus medulla showed a correlation with germinal centre formation in the thyroid. On the other hand, patients with Hashimoto's thyroiditis tended to have large thymic shadows radiologically but relatively little thymic tissue and rather few germinal centres in the medulla. At the present time, these findings are difficult to interpret but are unlikely to be entirely due to the differences in thyroid function in previous years.
In Addison's disease, although increased lymphocytic infiltration has been described in the thymic medulla, no distinction has been made in post-mortem studies between patients with idiopathic (that is autoimmune) Addison's disease and those in whom the adrenal destruction was tuberculous or due to some other cause.
In systemic lupus erythematosus the thymus tends to be smaller than normal, even in patients who have not-'"eviously been given steroid therapy (see Goldstein & Mackay 1969) . Although germinal centre formation may occur, the most conspicuous feature is the occurrence of spindleepithelial cells, plasma cells and numerous cystic Hassall's corpuscles.
Henry (1968) has compared the histology of the thymus in patients with rheumatic heart disease and congenital heart disease. The thymus biopsies were taken during cardiac surgery. Germinal centres in the thymic medulla were more frequent and more conspicuous in the patients with rheumatic heart disease. In the past it has been denied that germinal centres occur in normal subjects, but it does seem that they do occur but to a lesser extent than in patients with certain autoimmune diseases.
ANIMAL MODELS

NZB Mice
The NZB strain of mice that develop autoimmune hiemolytic anemia spontaneously and show evidence of glomerulonephritis have a high incidence of germinal centre formation in the thymic medulla developing in adult life (Burnet & Holmes 1964) . The time of onset of the thymic changes does not have a close correlation with the appearance of positive Coombs tests. The mice all develop positive Coombs tests and thymic changes with increasing age.
It may be that the germinal centres in the thymus in autoimmune disease are the site of production of forbidden clones of lymphocytes that seed out into the lymphoid system and which are responsible for the production of self-reactive immunity. Alternatively, the normal thymus may have a censorship function, whereby it somehow deletes any aberrant clones of lymphocytes that might arise, for example, by spontaneous mutation (Burnet 1962 , Miller & Osoba 1967 . It may be that the thymus in order to do this has a repertoire of the antigens that are present throughout the various tissues of the body.
There is evidence, however, that the thymus is not primarily involved in causing the autoimmune disease in NZB mice. For example, neonatal thymectomy in NZB mice does not prevent the onset of autoimmune hmmolytic anemia although germinal centre formation in the thymic medulla does not appear in these animals until they are much older. Grafting of a normal thymus into an autoimmune strain does not prevent the development of the hxemolytic anemia or of the renal disease (Howie & Helyer 1966) . Thymic grafts inserted into NZB mice develop lesions similar to those occurring in the animal's own thymus. This suggests that the thymus is a target organ, being one further site in which pathological evidence of an autoimmune reaction can be found (Holmes & Burnet 1966) .
On the other hand, there is evidence that the autoimmune disease in NZB mice is initiated by a vertically transmitted virus. Thus, autoimmune disease with positive Coombs and LE cell tests can be transmitted to other strains of mice by grafts of thymus from autoimmune strains, by inocula of spleen cells and most significantly by cell-free extracts from spleen. Virus particles can be consistently demonstrated by electromicroscopy in the tissues of NZB mice and the development of positive Coombs tests can be significantly delayed by vaccinating baby NZB mice with formaldehyde-inactivated cell-free filtrates of older NZB mouse spleens (Mellors 1969).
The NZB mice, by nature of their inbreeding, may be particularly susceptible to a certain type of virus infection. It can be postulated that the virus induces autoimmunity by altering the cells' antigens sufficiently to render these antigenic, and the immune reaction thus stimulated cross-reacts with normal antigens. In this way, an autoimmune reaction may be set up and the thymus may be involved as a target organ.
Animal Modelsfor Myasthenia Gravis
Spontaneously occurring (Mastomys): A high incidence of thymomas has been described in the species of South African rodent called Mastomys and some of these animals have myositis and atrophy of skeletal muscle. Nearly a third of the animals with thymomas have severe myocarditis. Strauss et al. (1968) recently described the presence of circulating antibody in the serum of such an animal with a thymoma that was reactive with cardiac and skeletal muscle striations in a manner comparable to the antibody found in patients with myasthenia gravis. It would, therefore, appear that these animals provide an experimental model approaching that of thymomatous myasthenia gravis in man. The literature on the experimental production of myasthenia gravis is conflicting, but a positive finding is likely to be more significant than a negative one, particularly when imm tion procedures are involved. Goldstein & Whittingham (1966 , 1967 and Kaldn et al. (1969) have shown that it is possible to produce an experimental model of myasthenia gravis in guinea-pigs or rats by immunizing the animals with skeletal or thymic extracts together with Freund's adjuvant via the foot pads. In the thymus of the normal guinea-pig there is an even distribution of lymphocytes throughout the medula. The majority of animals immunized with skeletal muscle or thymus showed a marked infiltration of lymphocytes around the Hassall's corpusdes in the thymus (Fig 1) . There was no change in the weight of the thymus or in the ot-her histolbgical components. This appearance in the thymus is referred to as a 'thymitis' as it does seem to be due to an immune action against an antigenic component ofthe thymus.
As demonstrated by the indirect immunofluorescence technique, the immunized guineapigs produced circulating antibody reactive with skeletal and cardiac muscle striations and with myoid cells in the thymus. The control animals injected with lymph-node extract or with saline in Freund's adjuvant did not produce these antibodies.
Evidence for a defect in neuromuscular transmission was looked for in these animals comparable to that found in myasthenia gravis using the techniques of electromyography. The behaviour of the first 10 muscle action potentiab during tetanic supramaximal nerve stimulation was used to study the neuromuscular transmission in the:control animals and in the animals immunized with thymus or skeletal muscle (Fig 2) . In the control animals, the height of the amplitudes of the first 10 action potentials nornally showed a slight increase or remained constant. In a signifnt number of the imnized animals, there was a rapid decline in the successive musde respones smilar to that described in patients with myasthenia gravis. Five to 10 minutes after height ofthe successive muscle responses is maintained; the height ofthefirst action potential as shown is foreshortened by the photographic tube. B, decreasing response in an animal immunized with calfheart muscle in CFA and in which thymitis waspresent; the tenth action potential is 36-6% ofthefirst. (Reproduced from Kalden et al., 1969, kindpermission) the injection of Tensilon, a significant improvement in the muscle tetanus pattern was recorded in all guinea-pigs with a partial neuromuscular block. In the majority, the pattern returned to normal.
The development of this partial neuromuscular block was found to be thymus dependent. Animals that had been thymectomized did not develop neuromuscular block on immunization with thymus or skeletal muscle. Furthermore, in animals in which a partial neuromuscular block had been induced, the tetanus pattern returned to normal within 3-4 days of thymectomy, as opposed to 7-10 days without thymectomy (Kalden et al. 1970) . All the animals showing partial neuromuscular block had histological evidence of thymitis. The production of thymitis does seem to be an essential step in inducing neuromuscular block by immunological means. Some recent publications (Vetters et al. 1969 , Kaufman et al. 1969 ) deny that a myasthenia-like syndrome can be induced in experimental animals by immunological techniques. However, these papers do not give a histological description of thymitis. According to the hypothesis discussed above, a partial neuromuscular block would not be expected in the absence of experimental thymitis. A further positive finding was that of Goldstein & Hofmann (1968) who showed that the miniature end-plate potentials were significantly reduced in appropriately immunized animals in contrast to the controls, again in keeping with the findings in human myasthenia gravis.
Several workers have shown that thymic extracts may have a blocking effect on neuromuscular transmission. Recently, Goldstein & Hofmann (1969) have given further support to the concept that the thymus may secrete a substance, thymin, which affects neuromuscular transmission. This substance may be released in excess following severe histological lesions in the thymus, such as may occur in myasthenia gravis in man or be induced experimentally by immunization in animals. There is no evidence that this neuromuscular blocking substance is an antibody.
THYMECTOMY IN PATIENTS WITH AUTOIMMUNE DISEASE
The only human autoimmune disease for which thymectomy is regularly performed is myasthenia gravis. It has its best effects in females with nonthymomatous myasthenia gravis, particularly when the pre-operative duration of the disease has been short (Keynes 1954 , Simpson 1958 . This would be compatible with the experimental studies described above.
Thymectomy has also been successful in 2 infants with intractable autoimmune hvmolytic anemia (Wilmers & Russell 1963 , Karaklis et al. 1964 . Apart from these examples, thymectomy has not produced beneficial results in relation to autoimmunity in adults when it has been tried, for example, in systemic lupus erythematosus (Mackay & Smalley 1966) . Thymectomy as a treatment for autoimmune disease other than myasthenia gravis may be effective only in childhood when the influence of the thymus on the immunological system is particularly pertinent.
In conclusion, we are clearly a long way from fully understanding the role of the thymus in relation to autoimmunity. I have tried to describe and to interpret the facts that have emerged so far.
